XML 19 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents $ 100,899us-gaap_CashAndCashEquivalentsAtCarryingValue $ 89,215us-gaap_CashAndCashEquivalentsAtCarryingValue
Short-term marketable securities 135,337us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent 165,396us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent
Accounts receivable, net of allowances of $433 and $87 at March 31, 2015 and December 31, 2014 565us-gaap_AccountsReceivableNetCurrent 289us-gaap_AccountsReceivableNetCurrent
Receivables from collaborative arrangements 19,660tbph_ReceivablesFromCollaborationPartners 1,840tbph_ReceivablesFromCollaborationPartners
Prepaid and other current assets 6,758us-gaap_PrepaidExpenseAndOtherAssetsCurrent 6,084us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Inventories 12,337us-gaap_InventoryNet 12,546us-gaap_InventoryNet
Total current assets 275,556us-gaap_AssetsCurrent 275,370us-gaap_AssetsCurrent
Marketable securities 38,521us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent 51,399us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
Restricted cash 833us-gaap_RestrictedCashAndCashEquivalentsNoncurrent 833us-gaap_RestrictedCashAndCashEquivalentsNoncurrent
Property and equipment, net 9,305us-gaap_PropertyPlantAndEquipmentNet 9,663us-gaap_PropertyPlantAndEquipmentNet
Other assets 686us-gaap_OtherAssetsNoncurrent 506us-gaap_OtherAssetsNoncurrent
Total assets 324,901us-gaap_Assets 337,771us-gaap_Assets
Current liabilities:    
Accounts payable 4,021us-gaap_AccountsPayableCurrent 9,921us-gaap_AccountsPayableCurrent
Accrued personnel-related expenses 10,433us-gaap_EmployeeRelatedLiabilitiesCurrent 18,156us-gaap_EmployeeRelatedLiabilitiesCurrent
Accrued clinical and development expenses 6,628tbph_AccruedClinicalAndDevelopmentExpensesCurrent 7,871tbph_AccruedClinicalAndDevelopmentExpensesCurrent
Other accrued liabilities 7,460us-gaap_OtherLiabilitiesCurrent 5,219us-gaap_OtherLiabilitiesCurrent
Deferred revenue 310us-gaap_DeferredRevenueCurrent 89us-gaap_DeferredRevenueCurrent
Total current liabilities 28,852us-gaap_LiabilitiesCurrent 41,256us-gaap_LiabilitiesCurrent
Deferred rent 5,044us-gaap_DeferredRentCreditNoncurrent 5,150us-gaap_DeferredRentCreditNoncurrent
Other long-term liabilities 1,890us-gaap_OtherLiabilitiesNoncurrent 1,578us-gaap_OtherLiabilitiesNoncurrent
Commitments and contingencies (Notes 3 and 8)      
Shareholders' Equity    
Preferred shares, $0.00001 par value: 230 shares authorized, no shares issued or outstanding at March 31, 2015 and December 31, 2014      
Ordinary shares, $0.00001 par value: 200,000 shares authorized at March 31, 2015 and December 31, 2014; 33,802 and 32,221 shares issued and outstanding at March 31, 2015 and December 31, 2014      
Additional paid-in capital 470,895us-gaap_AdditionalPaidInCapital 429,206us-gaap_AdditionalPaidInCapital
Accumulated other comprehensive income (loss) 31us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax (82)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Accumulated deficit (181,811)us-gaap_RetainedEarningsAccumulatedDeficit (139,337)us-gaap_RetainedEarningsAccumulatedDeficit
Total shareholders' equity 289,115us-gaap_StockholdersEquity 289,787us-gaap_StockholdersEquity
Total liabilities and shareholders' equity $ 324,901us-gaap_LiabilitiesAndStockholdersEquity $ 337,771us-gaap_LiabilitiesAndStockholdersEquity